Sompo Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.87M Buy
3,230
+20
+0.6% +$20.4K 0.64% 39
2026
Q1
$2.95M Sell
3,210
-160
-5% -$162K 0.54% 46
2025
Q4
$3.62M Sell
3,370
-150
-4% -$143K 0.62% 40
2025
Q3
$2.69M Sell
3,520
-50
-1% -$37.2K 0.46% 46
2025
Q2
$2.78M Buy
3,570
+60
+2% +$46.6K 0.48% 44
2025
Q1
$2.9M Hold
3,510
0.54% 47
2024
Q4
$2.71M Sell
3,510
-470
-12% -$389K 0.46% 50
2024
Q3
$3.53M Buy
3,980
+110
+3% +$98.9K 0.55% 48
2024
Q2
$3.5M Sell
3,870
-280
-7% -$224K 0.59% 47
2024
Q1
$3.23M Buy
4,150
+390
+10% +$278K 0.53% 49
2023
Q4
$2.19M Buy
3,760
+3,290
+700% +$1.92M 0.4% 56
2023
Q3
$252K Buy
+470
New +$242K 0.06% 172

Other funds holding LLY

Sompo Asset Management's LLY Position: Q2 2026 in Review

Sompo Asset Management increased its Eli Lilly (LLY) stake by 0.62% in Q2 2026, buying an estimated $20.4K and bringing the position to 3,230 shares worth $3.87M. The position accounts for 0.64% of the portfolio, ranked #39.

Sompo Asset Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. 841 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Sompo Asset Management held 3,230 shares of Eli Lilly worth $3.87M as of Q2 2026.
  • Sompo Asset Management bought 20 Eli Lilly shares in Q2 2026, an estimated $20.4K.
  • Eli Lilly made up 0.64% of Sompo Asset Management's portfolio in Q2 2026, its #39 holding.
  • Sompo Asset Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • 841 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Sompo Asset Management's 13F filing for Q2 2026, filed 14 Jul 2026.